Morphosys - The pipeline is full to bursting

In 2021, 18.7 million people received the shocking diagnosis of "cancer". Current trends, unfortunately, suggest that this number will continue to rise in the coming years. Thanks to growing research successes, however, there is hope that biotechnology will make survival more likely for those affected. It is a matter of developing suitable active substances and launching modern therapies. Why some people get cancer, and others do not is unclear. The Munich-based biotechnology company is looking for suitable answers and is very far advanced with its current pipeline. Is the next blockbuster lurking here?

Den vollständigen Artikel lesen ...